Back to Blog
Oura Filed Its IPO Paperwork. Here Is What the Company Told the SEC About Your Health Data.

Oura Filed Its IPO Paperwork. Here Is What the Company Told the SEC About Your Health Data.


Oura filed its initial public offering (IPO) paperwork with the Securities and Exchange Commission (SEC) on September 3, 2026.[1] The company sells a titanium ring, worn day and night, along with a monthly membership that turns the ring's readings into sleep, readiness, and activity scores. The filing, a Form S-1, is the first audited look at that business.

Two parts of the document matter if you wear one. The audited numbers show how big the business has become. The regulatory section states what the company believes the ring is for.

What the Filing Actually Says

The registrant is Oura Inc., headquartered at 415 Kearny Street in San Francisco.[1] Press coverage often calls Oura a Finnish company, and the product was designed in Oulu, Finland. The entity going public is the San Francisco one. Oura plans to list on the Nasdaq under the ticker "OURA," with Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Company, and Jefferies as lead book-runners.[1] Trade coverage read the filing as a pitch to investors on artificial intelligence (AI) and preventive health.[2][3]

Here is what the S-1 reports:[1]

  • Revenue, nine months ended June 30, 2026: $1.215 billion, against $697.6 million a year earlier. That is 74% growth.

  • Revenue, full fiscal years: $406.8 million in fiscal 2024, rising to $907.9 million in fiscal 2025. That is 123% growth.

  • Revenue mix for those nine months: $974.0 million from hardware, about 80% of the total. Membership brought in $240.5 million.

  • Gross margin: 55%, up from 51%. That is the share of revenue left after the cost of making and shipping the product.

  • Net income: $60.8 million, against $1.6 million a year earlier.

  • Adjusted EBITDA: $106.7 million, against $83.5 million. That is a profit measure that leaves out interest, taxes, and non-cash charges.

  • Paid Members: 5.0 million, across 56 markets.

  • Retention: weighted-average 12-month paid-member retention of approximately 85%.

  • Wear time: in the third quarter of fiscal 2026, paid members wore the ring a median of about 23 hours a day.

Membership revenue of $240.5 million is a subscription business at scale, and a median wear time near 23 hours a day means the ring is recording almost continuously.

What the filing does not say

Nothing in the S-1 states a share price, a deal size, or a valuation. Those numbers arrive later, in an amended filing, once the company and its banks set a price range. Before the filing, Bloomberg reported on August 24, 2026 that Oura was seeking to raise up to $3 billion at a valuation above $16 billion, citing people familiar with the matter.[5] Axios carried the report the next day.[6] Treat those figures as press reporting. Oura had already submitted a confidential draft registration to the SEC on May 19, 2026, the private first step toward a public filing.[1][7]

Oura Tells the SEC the Ring Is a General Wellness Product

One passage in the filing's risk factors bears directly on how you should use the ring. Oura states that it markets the ring and certain app features as general wellness products.[1] It says it believes those products are either excluded from the definition of a medical device under Section 201(h) of the Federal Food, Drug, and Cosmetic Act, or that they fall under FDA enforcement discretion for low-risk general wellness products described in the FDA's January 2026 guidance, "General Wellness: Policy for Low Risk Devices."[1][4]

In plain words, the company tells investors the ring is intended to help people maintain a healthy lifestyle. The filing states the ring is not intended for the diagnosis, cure, mitigation, prevention, or treatment of any disease.[1] Oura warns that if the FDA disagreed, the company would face costly and ongoing regulatory obligations.[1]

That disclosure comes from the manufacturer, in a document the SEC reviews and investors rely on.

What "General Wellness" Means When You Are Making a Health Decision

A general wellness product can tell you that something changed. It cannot tell you what the change means.

Say your resting heart rate has run 7 beats per minute above your 90-day baseline for eight straight nights. The ring is good at that observation. It holds the baseline, the trend, and the deviation. It cannot decide whether the cause is a new thyroid problem, the 10 mg of escitalopram you started in October, three weeks of short sleep, alcohol, or an early infection. Each explanation leads somewhere different. One needs a thyroid-stimulating hormone (TSH) blood test. One needs a medication review. One needs a week of rest.

A physician does that sorting. Your doctor reads the trend alongside your history, your medication list, your exam, and a lab result when one is warranted. The ring produces the signal, and the physician decides what to do next.

Nighttime breathing measurements work the same way. A repeated flag is a reasonable reason to order a home sleep apnea test.[11] The test makes the diagnosis.

A separate accuracy dispute is running alongside the filing. A proposed class action, Surber v. Oura, was filed in San Francisco federal court on August 20, 2026, arguing that Oura overstated how accurately the ring identifies sleep stages.[12] Oura disputes the allegations, and no court has ruled.

Who Built Oura

Oura Health was founded in 2013 in Oulu, Finland, by Petteri Lahtela, Kari Kivelä, and Markku Koskela.[13] The company funded its first-generation ring through a Kickstarter campaign in 2015 and launched it at the Slush technology conference in Helsinki.[13] Petteri Lahtela was the founding chief executive. Harpreet Singh Rai held the role from 2018 to 2021, and Tom Hale became chief executive in 2022.[13]

Oura has made four acquisitions on record: Proxy, a digital identification company, in May 2023; Veri, a metabolic health company, in September 2024; Sparta Science, an enterprise health analytics company, in October 2024; and Galen AI, a medical-records data company, in April 2026.[7][13] Its valuation went from $5.2 billion at a Series D in December 2024 to $11 billion at a Series E of more than $900 million in October 2025, led by Fidelity Management & Research.[13][14] Total private funding is roughly $1.5 billion.[14]

What the Ring Collects and Who Can See It

Oura's privacy policy, effective June 15, 2026, lists what the company collects.[8]

  • Measured data: heart rate, movement, temperature, and respiration.

  • Calculated health data: sleep phases, activity levels, and readiness.

  • User-provided data: activities, notes, photos, tags, and any health records you import.

  • Account and device data: email, address, gender, height, weight, IP address, location, and payment details.

According to the policy, "Oura does not sell or rent your personal information."[8] Oura shares data with service providers for storage and analytics, with research sponsors under a separate consent, and with integrations such as Apple HealthKit and Google Health Connect when you turn them on.[8]

An Enterprise Platform lets you share ring data with a doctor, coach, employer, or insurer. The invitation states the scope, type, and time period of the data requested.[8] Once you accept, the recipient "becomes the controller of your personal data."[8] You can withdraw consent later, but you cannot recall data already transferred.[8]

Those sharing pathways are also the growth story in the filing. Oura members can chat with a medical AI service from Counsel Health inside the app and add a licensed physician to the conversation.[9] Resmed, a sleep and breathing device company, routes members with frequent nighttime breathing disturbances to a sleep assessment.[11] Essence Healthcare, a Medicare Advantage insurer, covers the ring for some plan members and, with consent, screens their breathing data for sleep apnea risk before sending results to the member's own physician.[10] Eli Lilly made an equity investment in Oura in July 2026, with the amount undisclosed.[15]

A private company can run those as experiments. A public company reports on them every quarter. The direction of travel is more ring data flowing to more parties, with your consent, more often.

HIPAA does not cover most of it

Oura's policy says plainly that "Oura is generally not a Covered Entity under HIPAA for our direct-to-consumer Services."[8] The Health Insurance Portability and Accountability Act (HIPAA) applies to health plans, providers, and their contractors. Federal guidance for health app developers, published by the Federal Trade Commission (FTC) and pointed to by the Department of Health and Human Services (HHS), states that "the HIPAA Rules do not apply to health information maintained by anyone who isn't a covered entity or business associate," even when the information came from a doctor's office.[16][17]

Consider what happens when you import your medical records into the Oura app. Those records "no longer fall under HIPAA while they are in Oura's possession," the policy says.[8] The FTC Act, which prohibits unfair or deceptive practices around personal data, still applies to app developers.[16][17] Consumer-protection rules like that one are weaker than the access and disclosure limits HIPAA places on your doctor's chart.

Paying for the ring with health dollars

The ring and the membership can be bought with Health Savings Account (HSA) or Flexible Spending Account (FSA) funds, according to Oura's support page, which advises checking with your plan first.[18] Insurance coverage is narrower, and the Essence Healthcare benefit is the model Oura is building toward.[10] For most people the ring is an out-of-pocket purchase of $399 to $499 plus the membership.[19]

How a Concierge or DPC Doctor Uses Ring Data

The ring is useful in a visit when a doctor treats it as a trend log. NextMD's earlier article found that doctors usually see the data patients bring but rarely get it into the chart: Your Doctor Sees Your Wearable Data, but Almost Never Has It in the Chart.

What ring data supports well:

  • Resting heart rate and heart rate variability trends over 30 to 90 days, which give a doctor a starting point better than "I have felt tired lately."

  • Nighttime breathing disturbances, which can justify ordering a home sleep apnea test.[11]

  • Medication context. If you take a GLP-1 drug such as semaglutide or tirzepatide, the app's dose log alongside sleep and heart rate data gives your doctor a timeline the pharmacy record does not.[15]

  • A shareable report. Oura exports a PDF covering 7, 30, or 90 days of sleep time, wake time, restfulness, and movement, built for handing to a physician.[20]

Where ring data stops:

  • It does not measure blood pressure. The Ring 5 tracks patterns that may suggest cardiovascular strain.[19]

  • It does not replace a sleep study. Sleep staging is an estimate built from pulse, movement, and temperature.[12]

  • It does not diagnose, which is Oura's own position in the S-1.[1]

Reading a trend line takes time in the room. A traditional primary care physician carries a panel of 2,000 to 2,500 patients and sees each one for 10 to 15 minutes. A concierge physician keeps a panel under 300 patients, and a direct primary care (DPC) physician keeps up to 800. Both run 30- to 60-minute visits, long enough to open a 90-day chart, ask about snoring, and order a home sleep test. Concierge memberships run $3,000 to over $40,000 per year. DPC runs $50 to $200 per month.

In Oura's home city, Castro Direct Primary Care charges $200 per month for family medicine with a single physician, according to NextMD directory data. That is a doctor who knows your baseline before the ring flags a deviation from it. You can compare it with other concierge and DPC practices in San Francisco on NextMD.

Counsel Health connects you to a licensed physician. A concierge or DPC membership connects you to your own physician, who will see the same trend line next quarter and the quarter after that. NextMD covered that difference when Oura first filed to go public.

FAQ

Did Oura file for an IPO?

Yes. Oura Inc. filed a Form S-1 with the SEC on September 3, 2026, and plans to list on the Nasdaq under the ticker "OURA."[1] A confidential draft registration went in on May 19, 2026.[1]

How much is Oura raising, and at what valuation?

The S-1 as filed does not state a deal size or a valuation. Those numbers come in an amended filing once a price range is set. Bloomberg reported before the filing that Oura was seeking up to $3 billion at a valuation above $16 billion.[5] That is press reporting rather than filed disclosure.

Is the Oura Ring a medical device?

Oura tells the SEC that it markets the ring and certain app features as general wellness products, which it believes are excluded from the medical device definition under Section 201(h) of the Federal Food, Drug, and Cosmetic Act or covered by FDA enforcement discretion under the January 2026 general wellness guidance.[1][4] The filing states the ring is not intended to diagnose, cure, mitigate, prevent, or treat any disease.[1]

Is my Oura data protected by HIPAA?

Generally, no. Oura's privacy policy states it is not a HIPAA covered entity for its direct-to-consumer services, and federal guidance says HIPAA does not apply to health information held by companies that are not covered entities or their contractors.[8][16][17]

Can my doctor use my Oura data?

Yes, as context. You can export a PDF report covering 7, 30, or 90 days, or share data through Oura's Enterprise Platform.[8][20] A physician can use trends in resting heart rate, breathing disturbances, and sleep duration to decide whether to order a test.

Does health insurance cover an Oura ring?

Rarely. Essence Healthcare covers the ring for some Medicare Advantage members.[10] Most buyers pay $399 to $499 for the ring plus a membership, and Oura says both are eligible for HSA and FSA funds, subject to your plan's rules.[18][19]

Find a Doctor Who Will Read the Trend Line

A ring on your finger produces a year of data. A physician with a small panel has time to read it. NextMD lists physician-led (MD/DO) concierge and DPC practices across the country. You can search by city, compare pricing, and view doctor credentials at nextmd.ai/search.

This article provides general educational information and is not medical, legal, or investment advice. If you have symptoms of a sleep disorder or a change in heart rate you are concerned about, consult a licensed physician who knows your medical history.

Written by Josh Bobrowsky, founder of NextMD.

Sources

  1. Oura Inc. (2026, September 3). Form S-1 Registration Statement. U.S. Securities and Exchange Commission, CIK 0002133022. Read the S-1 on SEC EDGAR

  2. Landi, H. (2026, September 3). Smart ring maker Oura files to go public, pitching investors on AI-driven preventive health. Fierce Healthcare. Read the Fierce Healthcare article

  3. MobiHealthNews. (2026, September 3). Oura files for IPO. Read the MobiHealthNews article

  4. U.S. Food and Drug Administration. (2026, January). General Wellness: Policy for Low Risk Devices. FDA guidance document. Read the FDA guidance page

  5. Lipschultz, B., & Gurman, M. (2026, August 24). Smart Ring Maker Oura Seeks to Raise Up to $3 Billion in US IPO. Bloomberg. Read the Bloomberg article

  6. Primack, D. (2026, August 25). Oura reportedly prepares $3 billion IPO. Axios. Read the Axios article

  7. Landi, H. (2026, May 26). Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth. Fierce Healthcare. Read the Fierce Healthcare article

  8. Oura Health Oy. (2026, June 15). ŌURA Health Privacy Policy. Read the Oura privacy policy

  9. Oura Team. (2026, June 8). Oura and Counsel Health Partner to Provide AI-Enabled Care. Oura, The Pulse Blog. Read the Oura post

  10. Minemyer, P. (2026, June 8). Essence Healthcare, Oura expand partnership to sleep apnea detection. Fierce Healthcare. Read the Fierce Healthcare article

  11. Resmed. (2026, May 19). Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care. Resmed Newsroom. Read the Resmed release

  12. Malik, A. (2026, August 21). Oura faces lawsuit accusing it of misleading consumers about sleep-tracking accuracy. TechCrunch. Read the TechCrunch article

  13. Wikipedia. (2026). Oura Health. Read the Wikipedia entry

  14. Yip, J. (2025, October 14). Oura reaches $11 billion valuation with new $900 million fundraise. CNBC. Read the CNBC article

  15. Oura Team. (2026, July 15). Lilly Makes an Equity Investment in Oura. Oura, The Pulse Blog. Read the Oura post

  16. U.S. Department of Health and Human Services, Office for Civil Rights. (2026, April 22). Resources for Mobile Health Apps Developers. HHS.gov. Read the HHS page

  17. Federal Trade Commission. Mobile Health App Interactive Tool. FTC.gov. Read the FTC tool

  18. Oura Member Care. (2026, June 9). Purchase with HSA or FSA Funds. Read the Oura support page

  19. Hagen, J. (2026, May 28). Oura unveils AI-enabled Oura Ring 5 with predictive health features. MobiHealthNews. Read the MobiHealthNews article

  20. Oura Team. (2024, August 30). Oura's Shareable Report Feature. Oura, The Pulse Blog. Read the Oura post


Related Posts